Table 3. Outcomes in study cohort.
| Referred for liver transplant | 31 (35%) |
|---|---|
| Underwent liver transplant | 11 (13.6%) |
| Reason why not referred | |
| Comorbidity | 17 (19.3%) |
| Alcohol/substance misuse/psychosocial issues | 19 (21.6%) |
| Frailty | 8 (9.1%) |
| Not specified | 8 (9.1%) |
| Recompensated | 3 (3.4%) |
| Unspecified MDT decision | 2 (2.3%) |
| Referred for TIPS | 6 (7%) |
| Underwent TIPS | 1 (1%) |
| Reasons why not referred | |
| Substance misuse/psychosocial issues | 11 (12.5%) |
| Serious comorbidity | 12 (13.6%) |
| Hepatic encephalopathy | 13 (14.8%) |
| Frailty | 10 (11.4%) |
| Unspecified MDT decision | 1 (1.1%) |
| Not specified | 20 (22.7%) |
| Recompensating/improvement of refractory ascites | 6 (6.8%) |
| Referred for transplant/listed | 8 (9.1%) |
| Advanced liver disease | 1 (1.1%) |
| Median number of large-volume paracentesis | 5 (IQR 3–8) |
MDT multi-disciplinary team, LTAD long-term ascitic drain, TIPS transjugular intrahepatic portosystemic shunt